{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:15:32Z","timestamp":1792131332163,"version":"4.4.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Previous trials suggest that vasopressin may improve outcomes in patients with vasodilatory shock. The aim of this study was to evaluate whether vasopressin could be superior to norepinephrine to improve outcomes in cancer patients with septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Single-center, randomized, double-blind clinical trial, and meta-analysis of randomized trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>ICU of a tertiary care hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Two-hundred fifty patients 18 years old or older with cancer and septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Patients were assigned to either vasopressin or norepinephrine as first-line vasopressor therapy. An updated meta-analysis was also conducted including randomized trials published until October 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      The primary outcome was all-cause mortality at 28 days after randomization. Prespecified secondary outcomes included 90-days all-cause mortality rate; number of days alive and free of advanced organ support at day 28; and Sequential Organ Failure Assessment score 24 hours and 96 hours after randomization. We also measure the prevalence of adverse effects in 28 days. A total of 250 patients were randomized. The primary outcome was observed in 71 patients (56.8%) in the vasopressin group and 66 patients (52.8%) in the norepinephrine group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.52). There were no significant differences in 90-day mortality (90 patients [72.0%] and 94 patients [75.2%], respectively;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.56), number of days alive and free of advanced organ support, adverse events, or Sequential Organ Failure Assessment score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In cancer patients with septic shock, vasopressin as first-line vasopressor therapy was not superior to norepinephrine in reducing 28-day mortality rate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004023","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T11:30:36Z","timestamp":1571052636000},"page":"1743-1750","source":"Crossref","is-referenced-by-count":54,"title":["Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial*"],"prefix":"10.1097","volume":"47","author":[{"given":"Ludhmila Abrah\u00e3o","family":"Hajjar","sequence":"first","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."},{"name":"Departamento de Cardiopneumologia, InCor, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Zambolim","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Belletti","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano Pinheiro","family":"de Almeida","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Section of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarice Hyesuk Lee","family":"Park","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Tizue","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Itala","family":"Rizk","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tais Felix","family":"Szeles","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor Cordeiro","family":"dos Santos Neto","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Kalil","family":"Filho","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."},{"name":"Departamento de Cardiopneumologia, InCor, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena Regina Barbosa Gomes","family":"Galas","sequence":"additional","affiliation":[{"name":"Instituto do Cancer, Hospital das Clinicas, Faculdade de Medicina de Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy."},{"name":"Vita-Salute San Raffaele University, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1473-3099(17)30322-5","article-title":"The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): An observational study.","volume":"17","author":"Machado","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc7713","article-title":"Characteristics and outcomes of cancer patients in European ICUs.","volume":"13","author":"Taccone","year":"2009","journal-title":"Crit Care"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/CCM.0b013e3181c0349e","article-title":"Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study.","volume":"38","author":"Soares","year":"2010","journal-title":"Crit Care Med"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"ofy313","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in intensive care unit patients: Worldwide data from the intensive care over nations audit.","volume":"5","author":"Sakr","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1097\/CCM.0000000000002722","article-title":"Time course of septic shock in immunocompromised and nonimmunocompromised patients.","volume":"45","author":"Jamme","year":"2017","journal-title":"Crit Care Med"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00134-017-4884-z","article-title":"The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/CCM.0000000000002283","article-title":"Liberal versus restrictive transfusion strategy in critically ill oncologic patients: The transfusion requirements in critically ill oncologic patients randomized controlled trial.","volume":"45","author":"Bergamin","year":"2017","journal-title":"Crit Care Med"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrclinonc.2012.106","article-title":"Thrombosis and cancer.","volume":"9","author":"Young","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SHK.0b013e3182810a0f","article-title":"Impact of a recent chemotherapy on the duration and intensity of the norepinephrine support during septic shock.","volume":"39","author":"Schnell","year":"2013","journal-title":"Shock"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012.","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress.","volume":"24","author":"D\u00fcnser","year":"2009","journal-title":"J Intensive Care Med"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00134-016-4249-z","article-title":"Catecholamines for inflammatory shock: A Jekyll-and-Hyde conundrum.","volume":"42","author":"Andreis","year":"2016","journal-title":"Intensive Care Med"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1164\/rccm.201604-0862CP","article-title":"Potentially inadvertent immunomodulation: Norepinephrine use in sepsis.","volume":"194","author":"Stolk","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock.","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock.","volume":"154","author":"Jentzer","year":"2018","journal-title":"Chest"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock.","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial.","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial.","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016.","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/cc11469","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: A systematic review and meta-analysis of nine randomized controlled trials.","volume":"16","author":"Serpa Neto","year":"2012","journal-title":"Crit Care"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"e0142605","DOI":"10.1371\/journal.pone.0142605","article-title":"Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials.","volume":"10","author":"Belletti","year":"2015","journal-title":"PLoS One"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: A systematic review and meta-analysis.","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1053\/j.jvca.2018.04.006","article-title":"Vasopressin in cardiac surgery: A meta-analysis of randomized controlled trials.","volume":"32","author":"D\u00fcnser","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc8224","article-title":"Bench-to-bedside review: Vasopressin in the management of septic shock.","volume":"15","author":"Russell","year":"2011","journal-title":"Crit Care"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","article-title":"Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: Implications for stress adaptation.","volume":"96","author":"Aguilera","year":"2000","journal-title":"Regul Pept"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200419656","article-title":"The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.","volume":"113","author":"Tanoue","year":"2004","journal-title":"J Clin Invest"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.","volume":"37","author":"Russell","year":"2009","journal-title":"Crit Care Med"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201302-0355OC","article-title":"Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.","volume":"188","author":"Russell","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","article-title":"Low-dose vasopressin in the treatment of vasodilatory septic shock.","volume":"47","author":"Malay","year":"1999","journal-title":"J Trauma"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","article-title":"Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial.","volume":"32","author":"Lauzier","year":"2006","journal-title":"Intensive Care Med"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): A randomized, controlled pilot study.","volume":"13","author":"Morelli","year":"2009","journal-title":"Crit Care"},{"key":"R34-20230728","first-page":"15","article-title":"The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: Microcirculation, is it the black box?","volume":"54","author":"Barzegar","year":"2016","journal-title":"Acta Med Iran"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4103\/ijccm.IJCCM_258_17","article-title":"Vasopressin in septic shock; assessment of sepsis biomarkers: A randomized, controlled trial.","volume":"21","author":"Barzegar","year":"2017","journal-title":"Indian J Crit Care Med"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock.","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin in adult patients with septic shock.","volume":"8","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/CCM.0000000000003471","article-title":"Renal outcomes of vasopressin and its analogs in distributive shock: A systematic review and meta-analysis of randomized trials.","volume":"47","author":"Nedel","year":"2019","journal-title":"Crit Care Med"},{"key":"R39-20230728","doi-asserted-by":"crossref","first-page":"194","DOI":"10.23736\/S0375-9393.18.13070-7","article-title":"Why do multicenter randomized controlled trials not confirm the positive findings of single center randomized controlled trials in acute care?","volume":"85","author":"Landoni","year":"2019","journal-title":"Minerva Anestesiol"},{"key":"R40-20230728","first-page":"F274","article-title":"Renal microvascular effects of vasopressin and vasopressin antagonists.","volume":"256","author":"Edwards","year":"1989","journal-title":"Am J Physiol"},{"key":"R41-20230728","article-title":"Renal autoregulation in experimental septic shock and its response to vasopressin and norepinephrine administration.","volume":"1985","author":"Post","year":"2018 Sep 27","journal-title":"J Appl Physiol"},{"key":"R42-20230728","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","article-title":"The interaction of vasopressin and corticosteroids in septic shock: A pilot randomized controlled trial.","volume":"42","author":"Gordon","year":"2014","journal-title":"Crit Care Med"},{"key":"R43-20230728","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock.","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"R44-20230728","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock.","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"R45-20230728","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study.","volume":"151","author":"Marik","year":"2017","journal-title":"Chest"},{"key":"R46-20230728","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13054-019-2420-y","article-title":"Broad spectrum vasopressors: A new approach to the initial management of septic shock?","volume":"23","author":"Chawla","year":"2019","journal-title":"Crit Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:04:36Z","timestamp":1690527876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004023","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}